DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/jcrx7m/20162020) has announced the addition of the "2016-2020 Emerging Opportunities in the Japanese Sexually-Transmitted Diseases (STD) Diagnostic Testing Market" report to their offering.
This new 280-page report from the publisher presents detailed analysis of the Japanese STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis. The report provides test volume and sales projections for Hospitals and Commercial/Private Labs.
In addition to market share and sales forecasts, the report:
- Examines market applications of Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, IT and other emerging technologies
- Reviews features and operating characteristics of major analyzers used for STD testing
- Profiles key suppliers and potential market entrants developing innovative technologies and products
Analyzes emerging opportunities, alternative market penetration
strategies, market entry barriers/risks, and strategic planning issues
The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products.
In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as a's proprietary data files was conducted.
Contains 280 pages and 17 tables
- Beckman Coulter/Danaher
- Becton Dickinson
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- ID Biomedical/GSK
- Ortho-Clinical Diagnostics
- Takara Bio
- Thermo Fisher/Life Technology
For more information visit http://www.researchandmarkets.com/research/jcrx7m/20162020